And we have also this: ANNAPOLIS, Md., April 3 /PRNewswire PharmAthene, Inc.'s Recombinant Butyrylcholinesterase (rBChE) Program the Subject of Promising New Alzheimer's Research. <A HREF="http://www.biospace.com/news_story.aspx?StoryID=51147&full=1" target="_blank">http://www.biospace.com/news_story.aspx?StoryID=51147&full=1</A> Important for GTCB?